Physiological risk factors for severe high-altitude illness: A prospective cohort study

American Journal of Respiratory and Critical Care Medicine

Volumn 185, Issue 2, 2012, Pages 192-198

  Richalet, Jean Paul ^a,b   Larmignat, Philippe ^a,b   Poitrine, Eric ^a   Letournel, Murielle ^b   Canouï Poitrine, Florence ^c,d  

^a UNIVERSITÉ PARIS 13   (France)

^b AVICENNE HOSPITAL   (France)

^c FACULTÉ DE MÉDECINE   (France)

^d HENRI MONDOR HOSPITAL   (France)

Author keywords

Acute mountain sickness; High altitude cerebral edema; High altitude pulmonary edema; Ventilatory response to hypoxia

Indexed keywords

ACETAZOLAMIDE;

ADULT; ALTITUDE DISEASE; ARTICLE; BRAIN EDEMA; CLINICAL FEATURE; DISEASE SEVERITY; FEMALE; HUMAN; HYPOXIA; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; MIGRAINE; PRIORITY JOURNAL; RISK FACTOR;

ACETAZOLAMIDE; ACUTE DISEASE; ADULT; ALTITUDE SICKNESS; BRAIN EDEMA; COHORT STUDIES; CONFIDENCE INTERVALS; DIURETICS; EXERCISE TEST; FEMALE; FRANCE; HEADACHE; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; ODDS RATIO; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84855982990     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201108-1396OC     Document Type: Article

References (39)

1. Ministry of Tourism, Nepal [Internet] [accessed 2011 Dec 12]. Available from: http://www.tourism.gov.np/uploaded/statistics2010.pdf
2. Hackett PH, Roach RC. High-altitude illness. N Engl J Med 2001;345: 107-114. (Pubitemid 32634570)
3. Hackett PH, Rennie D, Levine HD. The incidence, importance, and prophylaxis of acute mountain sickness. Lancet 1976;2:1149-1155.
4. Bloch KE, Turk AJ, Maggiorini M, Hess T, Merz T, Bosch MM, Barthelmes D, Hefti U, Pichler J, Senn O, et al. Effect of ascent protocol on acute mountain sickness and success at Muztagh Ata, 7546 m. High Alt Med Biol 2009;10:25-32.
5. Schneider M, Bernasch D, Weymann J, Holle R, Bärtsch P. Acute mountain sickness: influence of susceptibility, preexposure, and ascent rate. Med Sci Sports Exerc 2002;34:1886-1891. (Pubitemid 35440406)
6. Pesce C, Leal C, Pinto H, González G, Maggiorini M, Schneider M, Bärtsch P. Determinants of acute mountain sickness and success on Mount Aconcagua (6962 m). High Alt Med Biol 2005;6:158-166. (Pubitemid 41386665)
7. Ri-Li G, Chase PJ, Witkowski S, Wyrick BL, Stone JA, Levine BD, Babb TG. Obesity: associations with acute mountain sickness. Ann Intern Med 2003;19:253-257.
8. Honigman B, Theis MK, Koziol-McLain J, Roach R, Yip R, Houston C, Moore LG, Pearce P. Acute mountain sickness in a general tourist population at moderate altitudes. Ann Intern Med 1993;118:587-592. (Pubitemid 23102692)
9. Mairer K, Wille M, Bucher T, Burtscher M. Prevalence of acute mountain sickness in the eastern Alps. High Alt Med Biol 2009;10:239-245.
10. Richalet JP, Kéromès A, Dersch B, Corizzi F, Mehdioui H, Pophillat B, Chardonnet H, Tassery F, Herry JP, Rathat C, et al. Caractéristiques physiologiques des alpinistes de haute altitude. Sci Sports 1988;3:89-108.
11. Allemann Y, Hutter D, Lipp E, Sartori C, Duplain H, Egli M, Cook S, Scherrer U, Seiler C. Patent foramen ovale and high-altitude pulmonary edema. JAMA 2006;296:2954-2958. (Pubitemid 46021499)
12. Richalet JP, Chenivesse C, Larmignat P, Meille L. High altitude pulmonary edema, Down syndrome, and obstructive sleep apneas. High Alt Med Biol 2008;9:179-181. (Pubitemid 351913535)
13. Hackett PH, Creagh CE, Grover RF, Honigman B, Houston CS, Reeves JT, Sophocles AM, Van Hardenbroek M. High-altitude pulmonary edema in persons without the right pulmonary artery. N Engl J Med 1980;302:1070-1073. (Pubitemid 10123110)
14. Sartori C, Allemann Y, Trueb L, Delabays A, Nicod P, Scherrer U. Augmented vasoreactivity in adult life associated with perinatal vascular insult. Lancet 1999;353:2205-2207. (Pubitemid 29295254)
15. Richalet JP, Letournel M, Salama J. Holmes-Adie syndrome associated with high altitude pulmonary edema and low chemoresponsiveness to hypoxia. Clin Auton Res 2011;21:55-56.
16. Hackett PH, Roach RC, Schoene RB, Harrison GL, Mills WJ Jr. Abnormal control of ventilation in high-altitude pulmonary edema. J Appl Physiol 1988;64:1268-1272. (Pubitemid 18088552)
17. Matsuzawa Y, Fujimoto K, Kobayashi T, Namushi NR, Harada K, Kohno H, Fukushima M, Kusama S. Blunted hypoxic ventilatory drive in subjects susceptible to high-altitude pulmonary edema. J Appl Physiol 1989;66:1152-1157. (Pubitemid 19091343)
18. Milledge JS, Beeley JM, Broome J, Luff N, Pelling M, Smith D. Acute mountain sickness susceptibility, fitness and hypoxic ventilatory response. Eur Respir J 1991;4:1000-1003.
19. Rathat C, Richalet JP, Herry JP, Larmignat P. Detection of high-risk subjects for high altitude diseases. Int J Sports Med 1992;13:S76-S78.
20. Selland MA, Stelzner TJ, Stevens T, Mazzeo RS, McCullough RE, Reeves JT. Pulmonary function and hypoxic ventilatory response in subjects susceptible to high-altitude pulmonary edema. Chest 1993; 103:111-116. (Pubitemid 23027242)
21. Hohenhaus E, Paul A, McCullough RE, Kucherer H, Bärtsch P. Ventilatory and pulmonary vascular response to hypoxia and susceptibility to high altitude pulmonary oedema. Eur Respir J 1995;8:1825-1833.
22. Bärtsch P, Swenson ER, Paul A, Julg B, Hohenhaus E. Hypoxic ventilatory response, ventilation, gas exchange, and fluid balance in acute mountain sickness. High Alt Med Biol 2002;3:361-376. (Pubitemid 36305489)
23. Burtscher M, Szubski C, Faulhaber M. Prediction of the susceptibility to AMS in simulated altitude. Sleep Breath 2008;12:103-108.
24. Grünig E, Mereles D, Hildebrandt W, Swenson ER, Kübler W, Kuecherer H, Bärtsch P. Stress Doppler echocardiography for identification of susceptibility to high altitude pulmonary edema. J Am Coll Cardiol 2000;35:980-987. (Pubitemid 30189932)
25. Dehnert C, Grunig E, Mereles D, von Lennep N, Bärtsch P. Identification of individuals susceptible to high-altitude pulmonary oedema at low altitude. Eur Respir J 2005;25:545-551. (Pubitemid 40331187)
26. Mairbäurl H. Role of alveolar epithelial sodium transport in high altitude pulmonary edema (HAPE). Respir Physiol Neurobiol 2006;151: 178-191.
27. Wilson MH, Milledge J. Direct measurement of intracranial pressure at high altitude and correlation of ventricular size with acute mountain sickness: Brian Cummins' results from the 1985 Kishtwar expedition. Neurosurgery 2008;63:970-974.
28. MacInnis MJ, Koehle MS, Rupert JL. Evidence for a genetic basis for altitude illness: 2010 update. High Alt Med Biol 2010;11:349-368.
29. Richalet JP, Gimenez-Roqueplo AP, Peyrard S, Vé nisse A, Marelle L, Burnichon N, Bouzamondo A, Jeunemaitre X, Azizi M, Elghozi JL. A role for succinate dehydrogenase genes in low chemoresponsiveness to hypoxia? Clin Auton Res 2009;19:335-342.
30. Savourey G, Launay JC, Besnard Y, Guinet-Lebreton A, Alonso A, Sauvet F, Bourrilhon C. Normo- or hypobaric hypoxic tests: propositions for the determination of the individual susceptibility to altitude illnesses. Eur J Appl Physiol 2007;100:193-205. (Pubitemid 46681640)
31. Brugniaux JV, Schmitt L, Robach P, Jeanvoine H, Zimmermann H, Nicolet G, Duvallet A, Fouillot JP, Richalet JP. Living high-training low: tolerance and acclimatization in elite endurance athletes. Eur J Appl Physiol 2006;96:66-77. (Pubitemid 43013293)
32. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988;44:837-845.
33. Oelz O, Howald H, Di Prampero PE, Hoppeler H, Claassen H, Jenni R, Bühlmann A, Ferretti G, Brückner JC, Veicsteinas A, et al. Physiological profile of world-class high-altitude climbers. J Appl Physiol 1986;60:1734-1742. (Pubitemid 16088068)
34. Mollard P, Woorons X, Letournel M, Lamberto C, Favret F, Pichon A, Beaudry M, Richalet JP. Determinant factors of the decrease in aerobic performance in moderate acute hypoxia in women endurance athletes. Respir Physiol Neurobiol 2007;159:178-186. (Pubitemid 47570112)
35. Gaillard S, Dellasanta P, Loutan L, Kayser B. Awareness, prevalence, medication use, and risk factors of acute mountain sickness in tourists trekking around the Annapurnas in Nepal: a 12-year follow-up. High Alt Med Biol 2004;5:410-419. (Pubitemid 40309549)
36. Maggiorini M, Bühler B, Walter M, Oelz O. Prevalence of acute mountain sickness in the Swiss Alps. BMJ 1990;301:853-855. (Pubitemid 20342788)
37. Grissom CK, Roach RC, Sarnquist FH, Hackett PH. Acetazolamide in the treatment of acute mountain sickness: clinical efficacy and effect on gas exchange. Ann Intern Med 1992;116:461-465.
38. van Patot MC, Leadbetter G III, Keyes LE, Maakestad KM, Olson S, Hackett PH. Prophylactic low-dose acetazolamide reduces the incidence and severity of acute mountain sickness. High Alt Med Biol 2008;9:289-293.
39. Savourey G, Guinet A, Besnard Y, Garcia N, Hanniquet AM, Bittel J. Evaluation of the Lake Louise acute mountain sickness scoring system in a hypobaric chamber. Aviat Space Environ Med 1995;66:963-967.